Thymogen Protocol
Dosing & Research
Last Updated: September 4, 2026
Chemical Identity
- Amino Acid Sequence
- Glu-Trp
- Molecular Formula
- C16H19N3O5
- Molecular Weight
- 333.34 g/mol
- CAS Number
- 122933-59-9
Immune modulation, T-cell function support, Mucosal immunity studies, Recovery protocols
Half-Life
Short (dipeptide)
Administration
• Intranasal
• Intramuscular
Frequency
2 Times A Day Intranasal/1 Time Daily Injection
How It Works
- Immune modulation
- T-cell function support
- Mucosal immunity studies
- Recovery protocols
Dosing Structure
Dose
50–100 mcg
Frequency
2 Times A Day Intranasal/1 Time Daily Injection
Notes
Typically Administered As Defined Courses (10–20 Days) Repeated 1–2x Per Year Rather Than Continuous Daily Dosing. Based On Khavinson Institute And Associated Russian Clinical Research.
Example Protocols
Dose: 50–100 mcg
Frequency: 2 Times A Day Intranasal/1 Time Daily Injection
Duration: 3-20 days
Off Period: Not listed
Find Research Grade Thymogen
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year rather than continuous daily dosing.
•
Based on Khavinson Institute and associated Russian clinical research.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.